Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × peginterferon alfa-2b × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 17 Other hematologic neoplasm 14 Myeloid 12 Genitourinary 6 Lymphoid 4 CNS 4 Gastrointestinal 3 Other solid neoplasm 2 Gynecologic 2 Tumor-Agnostic 1 Sarcoma 1 Other neoplasm 1 Head & Neck 1

Conditions

Interventions

Radiotherapy 198 Cyclophosphamide 198 Doxorubicin 190 Temozolomide 169 Ifosfamide 112 Filgrastim 101 Etoposide 94 Imatinib Mesylate 91 Vincristine 86 Bevacizumab 77 Gemcitabine 76 Irinotecan 75 Magnetic Resonance Spectroscopy 69 pembrolizumab 65 Radiation 61 Carboplatin 59 pazopanib 56 Methotrexate 55 fludarabine phosphate 53 Cisplatin 53 Nivolumab 51 Specimen Handling 49 Peripheral Blood Stem Cell Transplantation 48 Trabectedin 44 Docetaxel 44 Biopsy 44 Busulfan 43 Melphalan 42 fludarabine 39 Paclitaxel 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00134030 2023-06-07

EURAMOS-1

Children's Oncology Group

Phase 3 Completed

1,334 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡